Genetics in inclusion body myositis
- PMID: 28777108
- PMCID: PMC5625970
- DOI: 10.1097/BOR.0000000000000431
Genetics in inclusion body myositis
Abstract
Purpose of review: To review the advances in our understanding of the genetics of inclusion body myositis (IBM) in the past year.
Recent findings: One large genetic association study focusing on immune-related genes in IBM has refined the association within the human leukocyte antigen (HLA) region to HLA-DRB1 alleles, and identified certain amino acid positions in HLA-DRB1 that may explain this risk. A suggestive association with CCR5 may indicate genetic overlap with other autoimmune diseases. Sequencing studies of candidate genes involved in related neuromuscular or neurodegenerative diseases have identified rare variants in VCP and SQSTM1. Proteomic studies of rimmed vacuoles in IBM and subsequent genetic analyses of candidate genes identified rare missense variants in FYCO1. Complex, large-scale mitochondrial deletions in cytochrome c oxidase-deficient muscle fibres expand our understanding of mitochondrial abnormalities in IBM.
Summary: The pathogenesis of IBM is likely multifactorial, including inflammatory and degenerative changes, and mitochondrial abnormalities. There has been considerable progress in our understanding of the genetic architecture of IBM, using complementary genetic approaches to investigate these different pathways.
Figures



References
-
- Needham M, Mastaglia FL. Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches. Lancet Neurol 2007; 6:620–631. - PubMed
-
- Broccolini A, Mirabella M. Hereditary inclusion: body myopathies. Biochim Biophys Acta - Mol Basis Dis 2015; 1852:644–650. - PubMed
-
- Needham M, Mastaglia FL, Garlepp MJ. Genetics of inclusion: body myositis. Muscle Nerve 2007; 35:549–561. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous